Literature DB >> 2169464

Body composition in cancer cachexia.

K C Fearon1, T Preston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2169464     DOI： 10.1159/000222558

Source DB:  PubMed          Journal:  Infusionstherapie        ISSN： 1011-6966


× No keyword cloud information.
  11 in total

1.  Bioelectrical impedance analysis predicts outcome in patients with suspected bacteremia.

Authors:  A Schwenk; L C Ward; M Elia; G M Scott
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

2.  Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang; Juntra Karbwang
Journal:  Eur J Clin Pharmacol       Date:  2018-07-05       Impact factor: 2.953

3.  Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline.

Authors:  F Prat; O Chapat; B Ducot; T Ponchon; J Fritsch; A D Choury; G Pelletier; C Buffet
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 4.  Biomarkers for cancer cachexia: is there also a genetic component to cachexia?

Authors:  B H L Tan; D A C Deans; R J E Skipworth; J A Ross; K C H Fearon
Journal:  Support Care Cancer       Date:  2007-12-11       Impact factor: 3.603

5.  Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.

Authors:  Zheng Liu; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-06-07       Impact factor: 4.335

Review 6.  Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.

Authors:  Stephanie E Reuter; Jennifer H Martin
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

7.  P-selectin genotype is associated with the development of cancer cachexia.

Authors:  Benjamin H L Tan; Torill Fladvad; Theodore P Braun; Antonio Vigano; Florian Strasser; D A Christopher Deans; Richard J E Skipworth; Tora S Solheim; Sambasivarao Damaraju; James A Ross; Stein Kaasa; Daniel L Marks; Vickie E Baracos; Frank Skorpen; Kenneth C H Fearon
Journal:  EMBO Mol Med       Date:  2012-04-04       Impact factor: 12.137

8.  Changes in nutritional status associated with unresectable pancreatic cancer.

Authors:  S J Wigmore; C E Plester; R A Richardson; K C Fearon
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Combination of telmisartan with cisplatin controls oral cancer cachexia in rats.

Authors:  Bhoomika M Patel; Deepak Damle
Journal:  Biomed Res Int       Date:  2013-12-05       Impact factor: 3.411

Review 10.  Pharmacokinetics of drugs in cachectic patients: a systematic review.

Authors:  Katja Trobec; Mojca Kerec Kos; Stephan von Haehling; Jochen Springer; Stefan D Anker; Mitja Lainscak
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.